Insider Transactions in Q2 2023 at G1 Therapeutics, Inc. (GTHX)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 15
2023
|
Garry A Nicholson |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+29.08%
|
-
|
Jun 15
2023
|
Alicia Secor |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+33.33%
|
-
|
Jun 15
2023
|
Jacks Lee |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
Jun 15
2023
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+4.87%
|
-
|
Jun 15
2023
|
Cynthia Schwalm |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+27.86%
|
-
|
Jun 15
2023
|
Norman Sharpless |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
May 22
2023
|
Monica R. Thomas Chief Legal & People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.91%
|
-
|
May 10
2023
|
John V. Umstead Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+27.16%
|
-
|
May 10
2023
|
Rajesh Malik Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+20.26%
|
-
|
May 10
2023
|
Mark Avagliano Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+31.21%
|
-
|
May 10
2023
|
Terry L Murdock Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+32.88%
|
-
|
May 10
2023
|
John E. (Jack) Bailey Jr. President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+26.83%
|
-
|
May 10
2023
|
Andrew Perry Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+38.34%
|
-
|